Similarly, it will be important to determine whether any of the recurrent genetic alterations in neuroblastoma such as MYCN amplification1, ALK gain-of-function mutation/amplification1, LIN28B overexpression62,63, and chromosome 1p or 11q loss64, contribute to defects in centrosome clustering. The gene discussed is MYCN; the disease is neuroblastoma.